Gates Foundation Funds Quantoom Biosciences to Halve mRNA Vaccine Production Costs
The Gates Foundation allocated $20 million to Quantoom Biosciences — the evolved form of Belgian biotech Univercells, which Gates had backed from 2016 — to develop compact, modular mRNA manufacturing systems designed to cut vaccine production costs by 50 percent. Quantoom's platform fits in a standard shipping container, enabling governments to establish domestic mRNA manufacturing at a fraction of the capital cost of conventional vaccine plants. The technology targets the structural bottleneck that keeps mRNA vaccines unaffordable in low-income countries.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Commits $100 Million to UNFPA Supplies Partnership
Next →
Gates Foundation and Wellcome Fund M72 Tuberculosis Vaccine Phase III Trial with $550 Million
Related Accomplishments
January 2026
Gates Foundation Awards $4.98 Million to Heritable Agriculture for AI-Driven Climate-Resilient Crop Genomics
In January 2026, the Gates Foundation awarded $4.98 million to Heritable Agriculture — an AI crop improvement company spun from Google X — for the JASON project, deploying a cloud-based AI genomics engine to identify drought and heat tolerance gene targets in staple crops for LMIC smallholder farmers. JASON aims to compress conventional crop breeding timelines and deliver climate-resilient germplasm faster to the nearly 2 billion people whose incomes depend on smallholder agriculture.
May 2026
Gates Foundation and Anthropic Launch $200 Million AI Partnership for Global Health and Smallholder Agriculture
On May 14, 2026, the Gates Foundation and Anthropic announced a $200 million four-year partnership — the largest between an AI company and a global philanthropy — combining grants, AI credits, and technical support. The partnership deploys AI to screen drug and vaccine candidates, detect patterns in systematic health reviews, and support smallholder farming decisions with locally customised crop knowledge in sub-Saharan Africa and India. Education initiatives include AI-powered tutoring for K-12 students and foundational literacy tools across Africa and India.
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.